Search results for "PULMONARY"

showing 10 items of 3030 documents

Airway Responsiveness to Adenosine 5′-Monophosphate and Exhaled Nitric Oxide Measurements

2003

Objectives To investigate the utility of the determination of airway responsiveness to inhaled adenosine 5′-monophosphate (AMP) and exhaled nitric oxide (ENO) levels as markers for safely reducing the dose of inhaled corticosteroids (ICS) in patients with asthma well controlled with a moderately high ICS dose. Methods A total of 37 patients with asthma well controlled for at least 3 months by treatment with a moderately high ICS dose (beclomethasone dipropionate, 500 to 1,000 μg or equivalent daily) were included in the study. Patients were treated for a 2-week run-in (baseline) period with their usual dose of ICS. For the next 12 weeks, patients were treated with ICS at half the previous d…

Pulmonary and Respiratory MedicineSpirometryInhalationmedicine.diagnostic_testbusiness.industrymedicine.drug_classCritical Care and Intensive Care Medicinemedicine.diseaseBronchodilatorAnesthesiaExhaled nitric oxidemedicineCorticosteroidBronchoconstrictionExpirationmedicine.symptomCardiology and Cardiovascular MedicinebusinessAsthmaChest
researchProduct

Persistent tachypnea of infancy: Follow up at school age

2020

Background Persistent tachypnea of infancy (PTI) is a rare pediatric lung disease of unknown origin. The diagnosis can be made by clinical presentation and chest high resolution computed tomography after exclusion of other causes. Clinical courses beyond infancy have rarely been assessed. Methods Patients included in the Kids Lung Register diagnosed with PTI as infants and now older than 5 years were identified. Initial presentation, extrapulmonary comorbidities, spirometry and clinical outcome were analyzed. Results Thirty-five children older than 5 years with PTI diagnosed as infants were analyzed. At the age of 5 years, 74% of the patients were reported as asymptomatic and did not develo…

Pulmonary and Respiratory MedicineSpirometryMaleHigh-resolution computed tomographyPediatricsmedicine.medical_specialtyRespiratory rateTachypneaAsymptomaticPulmonary function testing03 medical and health sciences0302 clinical medicine030225 pediatricsmedicineHumansChildTachypneaLungmedicine.diagnostic_testbusiness.industryInfantRespiratory Function Testsmedicine.anatomical_structure030228 respiratory systemChild PreschoolPediatrics Perinatology and Child HealthFemalePresentation (obstetrics)medicine.symptombusinessFollow-Up Studies
researchProduct

A cross-sectional study assessing the relationship between BMI, asthma, atopy, and eNO among schoolchildren

2011

Increased body weight may influence airway inflammatory mechanisms.To assess whether overweight-obesity (OW-O), evaluated as increased body mass index, is associated either with exhaled nitric oxide (eNO), a marker of airway inflammation, or with allergic sensitization in a large sample of children and adolescents.A cross-sectional, epidemiological study was performed on a population sample of schoolchildren evaluating 708 subjects (age 10-16 years; BMI 13-39 kg/m(2)) by respiratory health questionnaire, skin prick tests, spirometry, and eNO measure.Prevalence rates were: OW-O 16.4%, asthma ever (A) 11.9%, and rhinoconjunctivitis (RC) 14.8%. Asthma ever and allergic sensitization were signi…

Pulmonary and Respiratory MedicineSpirometryMaleObesity; Vital Capacity; Humans; Asthma; Child; Body Mass Index; Sicily; Forced Expiratory Volume; Nitric Oxide; Cross-Sectional Studies; Rhinitis Allergic Perennial; Logistic Models; Adolescent; Female; Male; PrevalenceVital capacitymedicine.medical_specialtyRhinitis Allergic PerennialLogistic ModelAdolescentImmunologyVital CapacityNitric OxideBody Mass IndexAllergic sensitizationAtopyFEV1/FVC ratioInternal medicineForced Expiratory VolumemedicinePrevalenceImmunology and AllergyHumansObesityRisk factorChildSicilyAsthmaCross-Sectional Studiemedicine.diagnostic_testbusiness.industrymedicine.diseaseAsthmarespiratory tract diseasesCross-Sectional StudiesLogistic ModelsAnesthesiaExhaled nitric oxideFemalebusinessHuman
researchProduct

Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.

2011

Two, once daily (q.d.) inhaled bronchodilators are available for the treatment of chronic obstructive pulmonary disease (COPD): the β(2)-agonist indacaterol and the anticholinergic tiotropium. This blinded study compared the efficacy of these two agents and assessed their safety and tolerability. Patients with moderate-to-severe COPD were randomised to treatment with indacaterol 150 μg q.d. (n=797) or tiotropium 18 μg q.d. (n=801) for 12 weeks. After 12 weeks, the two treatments had similar overall effects on "trough" (24 h post-dose) forced expiratory volume in 1 s. Indacaterol-treated patients had greater improvements in transition dyspnoea index (TDI) total score (least squares means 2.0…

Pulmonary and Respiratory MedicineSpirometryMalemedicine.drug_classScopolamine DerivativesQuinolonesSeverity of Illness IndexCholinergic AntagonistsDrug Administration ScheduleMedical Recordslaw.inventionPulmonary Disease Chronic ObstructiveRandomized controlled trialDouble-Blind MethodlawAdrenergic beta-2 Receptor AntagonistsForced Expiratory VolumemedicineAnticholinergicHumansTiotropium BromideAdverse effectAgedCOPDmedicine.diagnostic_testbusiness.industryTiotropium bromideMiddle Agedmedicine.diseaserespiratory tract diseasesBronchodilator AgentsTreatment OutcomeTolerabilitySpirometryAnesthesiaIndansIndacaterolFemalebusinessmedicine.drugThe European respiratory journal
researchProduct

Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD

2013

Expressing forced expiratory volume in 1 s (FEV1) as % predicted relies on the assumption of proportional variability and generalisability of prediction equations that may be unrealistic, especially for elderly people. We evaluated the prognostic implications of alternative ways of expressing FEV1. We enrolled 318 patients with chronic obstructive pulmonary disease (COPD) and 475 controls in the Salute Respiratoria nell'Anziano (SARA) study. The risk for 5-, 10- and 15-year mortality associated with FEV1 was studied by expressing FEV1 % pred, standardised by height cubed (FEV1 · Ht(-3)) and as a multiple of the sex-specific first percentile (FEV1 quotient (FEV1Q)). In the group with COPD, t…

Pulmonary and Respiratory MedicineSpirometryMalemedicine.medical_specialtyPediatricsPercentilePrognosiPulmonary diseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioRate ratioPulmonary Disease Chronic ObstructiveElderly populationInternal medicineForced Expiratory VolumeHumansMedicineElderly peopleRespiratory Function TestAgedCOPDmedicine.diagnostic_testbusiness.industryRespiratory Function Tests; Spirometry; Humans; Treatment Outcome; Prognosis; Case-Control Studies; Aged; Middle Aged; Forced Expiratory Volume; Male; Female; Pulmonary Disease Chronic ObstructiveCase-control studyrespiratory systemMiddle AgedPrognosismedicine.diseaseRespiratory Function Testsrespiratory tract diseasesTreatment OutcomeSpirometryCase-Control StudiesFemalebusinessCase-Control StudieHuman
researchProduct

PD48 - Relationship between Second Hand Smoke (SHS) exposure and atopy in social disadvantaged asthmatic children

2014

The evidence of a relationship between second hand smoke (SHS) exposure and atopy is inadequate. Smoke habit prevalence is higher in lower parental educational levels. The aim of this study was to investigate the relationship between SHS and atopy in asthmatic children focusing on socioeconomic status (SES). We studied 170 outpatient asthmatic children with different levels of asthma (GINA guidelines). Medical history was taken in standardized way to determine prevalence of SHS exposure and maternal smoking during pregnancy. Information about the highest level of parental education was collected as a proxy of SES level. All patients underwent skin prick test (SPT) and spirometry according t…

Pulmonary and Respiratory MedicineSpirometryPediatricsmedicine.medical_specialtyAllergyImmunologyPulmonary function testingAtopy030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineInternal medicinemedicineImmunology and AllergyAsthma2. Zero hungerSmokePregnancymedicine.diagnostic_testbusiness.industrymedicine.disease3. Good health030228 respiratory systemPoster Discussion PresentationbusinessBody mass indexClinical and Translational Allergy
researchProduct

PD13 ‐ Gender differences in rhinitic children

2014

Gender differential effects on rhinitis are infrequently studied. Aim of our study is to assess gender differences in host and environmental characteristics and in rhinitis severity level within the IBIM Pulmonary and Allergy Pediatric Clinic. A series of rhinitic (R) patients (September 2011 - May 2013) were investigated through standardized questionnaire and spirometry. Statistical analyses were performed with SPSS. Preliminary results refer to 122 R patients: 77 males (M) (63.1%) and 45 females (F) (36.9%); age (years): 9.23 ± 3.42M vs 9.38 ± 3.02F; maternal history of rhinitis: 45.5%M vs 32.3%F (p<0.090); exposure to maternal smoking during pregnancy:15.6%M vs 2.2%F (p<0.021); exposure …

Pulmonary and Respiratory MedicineSpirometryPediatricsmedicine.medical_specialtyAllergymedicine.diagnostic_testbusiness.industryImmunologyOverweightmedicine.diseaseGastroenterology3. Good healthPulmonary function testingFEV1/FVC ratioInternal medicineImmunology and AllergyMedicinePoster Discussion PresentationRisk factormedicine.symptombusinessBreast feedingAsthmaClinical and Translational Allergy
researchProduct

P120 Real life distribution of COPD severity in the German DACCORD registry: Lung function is the main driver of classification in GOLD group C and D

2015

Introduction Currently there is limited real-life data available regarding the distribution of COPD patients using the GOLD 2011 criteria. The German DACCORD registry that collects data from a large ‘real life’ population sample was used to categorise COPD patients according to GOLD 2011. Methods To be eligible for entry into DACCORD, all patients had to have a diagnosis of COPD (consistent with the German Disease Management Programme definition), and, prior to entry, had to have either newly initiated bronchodilator maintenance medication, or to have a bronchodilator added to their maintenance regimen. No other inclusion criteria were applied, and the only exclusion criterion was a diagnos…

Pulmonary and Respiratory MedicineSpirometryPediatricsmedicine.medical_specialtyCOPDExacerbationmedicine.diagnostic_testbusiness.industrymedicine.drug_classDiseasemedicine.diseaseRegimenBronchodilatormedicinebusinessLung functionAsthmaThorax
researchProduct

Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).

2015

Efficacy and safety of tiotropium+olodaterol fixed-dose combination (FDC) compared with the mono-components was evaluated in patients with moderate to very severe chronic obstructive pulmonary disease (COPD) in two replicate, randomised, double-blind, parallel-group, multicentre, phase III trials. Patients received tiotropium+olodaterol FDC 2.5/5 μg or 5/5 μg, tiotropium 2.5 μg or 5 μg, or olodaterol 5 μg delivered once-daily via Respimat inhaler over 52 weeks. Primary end points were forced expiratory volume in 1 s (FEV1) area under the curve from 0 to 3 h (AUC0–3) response, trough FEV1 response and St George's Respiratory Questionnaire (SGRQ) total score at 24 weeks. In total, 5162 patien…

Pulmonary and Respiratory MedicineSpirometryRespimatRespiratory Medicine and Allergy1Fixed-dose combinationOBSTRUCTIVE PULMONARY-DISEASEchemistry.chemical_compoundMedicine and Health SciencesmedicineCOPDCOPDmedicine.diagnostic_testbusiness.industryInhalerOlodaterolArea under the curveOriginal ArticlesTiotropium bromidemedicine.diseaserespiratory tract diseaseschemistryAnesthesiaTRIALbusinessmedicine.drug
researchProduct

Small airways function and molecular markers in exhaled air in mild asthma.

2005

Background: Several studies suggest that the periphery of the lung is the major site of inflammation in asthma. Fractional exhaled nitric oxide (FeNO) and 8-isoprostane have been proposed as biomarkers of inflammation and oxidative stress. We therefore hypothesised that small airway dysfunction in asthma is of inflammatory origin that can be detected by molecular markers in exhaled air. To test this hypothesis, we examined the relationship of FeNO and 8-isoprostane in exhaled air with small airways function as assessed by the single breath nitrogen test. Methods: Sixteen patients (14 women) with mild atopic asthma (forced expiratory volume in 1 second >80% predicted) of mean (SD) age 23.0 (…

Pulmonary and Respiratory MedicineSpirometrySmall airwayAdultMalemedicine.medical_specialtyVital CapacityEnzyme-Linked Immunosorbent AssaySettore MED/10 - Malattie Dell'Apparato RespiratorioDinoprostNitric OxideGastroenterologyNitric oxidechemistry.chemical_compoundInternal medicineForced Expiratory VolumemedicineHumansExhaled breath condensateBronchitisAsthmaLungmedicine.diagnostic_testbusiness.industryRespiratory diseaserespiratory systemmedicine.diseaseAsthmarespiratory tract diseasesmedicine.anatomical_structureCross-Sectional StudieschemistryExhaled nitric oxideImmunologyBronchitisFemalebusinessBiomarkersThorax
researchProduct